sugammadex sandoz 100 mg/ml sol. inj. i.v. flac.
sandoz sa-nv - sugammadex sodique 108,8 mg/ml - eq. sugammadex 100 mg/ml - solution injectable - 100 mg/ml - sugammadex sodique 108.8 mg/ml - sugammadex
sugammadex sandoz 100 mg/ml sol. inj. i.v. flac.
sandoz sa-nv - sugammadex sodique 108,8 mg/ml - eq. sugammadex 100 mg/ml - solution injectable - 100 mg/ml - sugammadex sodique 108.8 mg/ml - sugammadex
sugammadex mylan
mylan ireland limited - sugammadex sodium - blocus neuromusculaire - tous les autres produits thérapeutiques - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
sugammadex teva 100 mg/ml sol. inj. i.v. flac.
teva b.v. - sugammadex sodique 108,8 mg/ml - eq. sugammadex 100 mg/ml - solution injectable - 100 mg/ml - sugammadex sodique 108.8 mg/ml - sugammadex
sugammadex teva 100 mg/ml sol. inj. i.v. flac.
teva b.v. - sugammadex sodique 108,8 mg/ml - eq. sugammadex 100 mg/ml - solution injectable - 100 mg/ml - sugammadex sodique 108.8 mg/ml - sugammadex
sugammadex adroiq
extrovis eu ltd. - sugammadex sodium - blocus neuromusculaire - tous les autres produits thérapeutiques - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
sugammadex juta 100 mg/ml injektionslösung
"juta" pharma gmbh (8010239) - sugammadex-natrium - injektionslösung - 100 mg/ml - sugammadex-natrium (33574) 108,8 milligramm
sugammadex fresenius kabi
fresenius kabi deutschland gmbh - sugammadex sodium - neuromuskuläre blockade - alle anderen therapeutischen produkte - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
sugammadex fresenius kabi
fresenius kabi deutschland gmbh - sugammadex sodium - neuromuscular blockade - all other therapeutic products - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
sugammadex piramal
piramal critical care b.v. - sugammadex sodium - taugakerfi - sugammadex - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.